Rapid and progressive decline despite early intervention in a case of bilateral hemorrhagic occlusive retinal vasculitis.

PURPOSE: To present a case of severe bilateral hemorrhagic occlusive retinal vasculitis (HORV) after uncomplicated cataract surgery with intracameral vancomycin. We present a report of a single patient with bilateral presentation of HORV that demonstrated classic features of the disease and progressed to profound vision loss despite early and aggressive intervention. OBSERVATIONS: On initial presentation, the patient had good Snellen visual acuity of 20/25 PH 20/20 OD and 20/60 PH 20/30 OS with retinal hemorrhages in both eyes and sub-hyaloid hemorrhage in the left eye. Early therapeutic intervention with intravitreal corticosteroids, anti-vascular endothelial growth factor (anti-VEGF) agents and oral steroids was pursued. Even with treatment, the clinical picture rapidly deteriorated with progression of occlusive and hemorrhagic complications in both eyes resulting in bilateral ischemic retinopathy and breakthrough vitreous hemorrhage. After a prolonged course of treatment including the aforementioned along with panretinal photocoagulation (PRP) in both eyes and vitreoretinal surgery in the left eye, the final visual acuity was light perception (LP) OD and 20/100 OS. CONCLUSIONS AND IMPORTANCE: Hemorrhagic occlusive retinal vasculitis remains a feared complication of uncomplicated cataract surgery utilizing intracameral vancomycin. Despite early recognition and appropriate intervention, our patient still had a poor visual outcome with significant ischemic damage.

Management of cataract in the setting of uveitis: a review of the current literature.

PURPOSE OF REVIEW: This review aims to cover the preoperative planning, intraoperative considerations, and postoperative management that aids in successful outcomes of patients with cataract and uveitis. Disease-specific management and pediatric management will also be addressed. RECENT FINDINGS: Dexamethasone implants appear to be a safe and effective addition to standard steroid treatment in decreasing the incidence of postoperative cystoid macular edema (CME). Intravitreal steroids and topical difluprednate have shown utility in CME treatment. SUMMARY: Cataract surgery in eyes with uveitis is generally safe and effective if inflammation is well controlled; however, complication rates are still higher than in eyes without uveitis. Future investigations should delineate outcomes for eyes with different etiologies of uveitis, and further research is needed to adequately control inflammation and avoid postoperative complications.

Comparison of FDA-Reported Visual and Refractive Outcomes of the Toric ICL Lens, SMILE, and Topography-Guided LASIK for the Correction of Myopia and Myopic Astigmatism.

PURPOSE: To compare U.S. Food and Drug Administration (FDA)-reported visual and refractive outcomes following surgical correction of myopia and myopic astigmatism using the Visian Toric Implantable Collamer Lens (STAAR Surgical, Monrovia, CA) (Toric ICL), small incision lenticule extraction (SMILE), and topography-guided laser in situ keratomileusis (TG-LASIK). METHODS: FDA summary of safety and effectiveness data (SSED) were analyzed for each of the three platforms. Primary outcomes measured were efficacy, safety, stability, and accuracy of refractive correction. Stratified mean refractive spherical equivalent (MRSE) data were assessed. RESULTS: One hundred twenty-four Toric ICL patients (210 eyes), 357 SMILE patients (357 eyes), and 212 TG-LASIK patients (249 eyes) were included. SMILE eyes had a significant improvement in postoperative uncorrected distance visual acuity with respect to preoperative corrected distance visual acuity from 3 to 12 months (P < .001), whereas TG-LASIK had no further improvement from 3 to 12 months (P = .79). For preoperative MRSE greater than 10.00 diopters (D), there was a significant difference in the percentage of eyes achieving postoperative MSRE within ±0.50 D between Toric ICL (66%) and SMILE (100%) (P < .001). SMILE was consistently more accurate than Toric ICL for cylinder within ±0.25 D (P < .001), ±0.50 D (P < .001), and ±1.00 D (P = .0014). CONCLUSIONS: All three platforms analyzed in this study had excellent efficacy, safety, stability, and accuracy. Stratified analysis revealed that SMILE may be comparable to Toric ICL for patients with high myopia or myopic astigmatism, and SMILE may have a longer visual recovery compared to TG-LASIK than previously indicated. [J Refract Surg. 2019;35(11):699-706.].

Pentacam® Corneal Tomography for Screening of Refractive Surgery Candidates: A Review of the Literature, Part I.

Corneal tomography and Scheimpflug imaging are frequently used to analyze the corneal surface, especially in the field of cataract and refractive surgery. The Pentacam system is one of the most commonly used commercially available systems for this purpose. Through a rotating Scheimpflug camera, the system is capable of creating a three-dimensional map of the cornea. These advances in tomography have simultaneously enhanced the ability of clinicians to screen surgical candidates and detect subtle corneal changes in diseases such as keratoconus. However, there remains a need to enhance diagnosis in order to recognize mild and early forms of corneal ectasia. As iatrogenic ectasia and keratoconus are dreaded complications of refractive surgery, it is imperative to screen patients appropriately prior to surgery. The Pentacam is one of many systems utilized in the screening process, but the literature has not identified specific protocol nor parameters that are capable of carrying out this process appropriately. Post-operative keratoconus continues to occur despite the advances in technology seen in corneal imaging. Therefore, clear indices for screening are required in order to diagnose early forms of keratoconus and other corneal diseases that may exclude the seemingly asymptomatic patient from undergoing refractive surgery. This article aims to summarize the indices available on the Pentacam system and to identify the most accurate parameters for screening of the refractive surgery candidate.

Galilei Corneal Tomography for Screening of Refractive Surgery Candidates: A Review of the Literature, Part II.

Corneal topography is the most widely used technology for examining the anterior corneal surface. Scheimpflug imaging is a newer technique that allows for measurement of both the anterior and posterior corneal surface, which allows for three-dimensional reconstruction of the cornea. This is of particular interest and value in the field of cataract and refractive surgery. The Galilei camera is a commercially available dual Scheimpflug system that combines curvature data from Placido disc-based corneal topography with elevation data from Scheimpflug technology. The addition of Placido disc topography makes the Galilei unique from its more popular counterpart, the Pentacam, which was discussed in Part I. Compared to the Pentacam, and however, the Galilei analyzer is a newer system that has emerged as a valuable screening tool given its dual Scheimpflug capability. In the first article of this series, the authors summarized the refractive indices available on the Pentacam system with the purpose of identifying the best diagnostic parameters for keratoconus. Similarly, the purpose of this article is to summarize corneal surface indices available on the Galilei system and evaluate their use in screening of the refractive surgery candidate. Since post-operative keratectasia is still prevalent, this paper aims to identify the most clinically relevant indices that may be used in pre-operative evaluation.

Advances in Biomechanical Parameters for Screening of Refractive Surgery Candidates: A Review of the Literature, Part III.

Corneal biomechanical properties have garnered significant interest in their relation to the development of ectatic corneal disease. Alongside the advent of corneal tomography and Scheimpflug imaging such as Pentacam and Galilei, there have been advances in assessing the cornea based on its biomechanical characteristics. Though the aforementioned imaging systems are highly capable of identifying morphologic abnormalities, they cannot assess mechanical stability of the cornea. This article, in contrast to Parts I and II of this article series, will focus on in vivo corneal biomechanical imaging systems. The two most readily available commercial systems include the Corvis ST and the Ocular Response Analyzer. Both of these systems aimed to characterize corneal biomechanics via distinct measurements. While in Parts I and II of this article series the authors focused on elevation, pachymetric, and keratometric data, the purpose of this article was to summarize biomechanical parameters and their clinical use in screening refractive surgery candidates. Moreover, this article explores biomechanical decompensation and its role in the development of corneal ectasia and keratoconus. There is a focus on the diagnostic accuracy of biomechanical indices in the identification of diseases such as keratoconus that may preclude a patient from undergoing refractive surgery.

Presentation of Ocular Syphilis in a HIV-Positive Patient with False-Negative Serologic Screening.

PURPOSE: The ocular sequelae of syphilis are devastating and may cause blindness. The ambiguous nature of its ocular manifestations makes syphilis difficult to detect. Though uncommon, the rise of syphilis in the United States requires a renewed understanding of its ophthalmic presentation to prevent devastating outcomes. We present this case to raise awareness for the increasing prevalence of ocular syphilis and appropriate serologic testing. OBSERVATIONS: We describe a 65-year-old HIV-positive male with worsening retinitis, uveitis, and rapid visual loss. Initial lab results showed a nonreactive rapid plasma reagin (RPR) for syphilis. However, subsequent Treponema pallidum antibody testing was positive 48 hours after initial false-negative serologic screening. The patient had a rapid and successful recovery following treatment with penicillin. CONCLUSIONS AND IMPORTANCE: The incidence of syphilis is on the rise once again, and patients living with HIV are at increased risk. Ocular syphilis should be considered in susceptible populations in the clinical setting of retinitis, uveitis, and worsening visual loss with unknown cause. In addition, retesting for syphilis will decrease the prevalence of false-negative results, especially in patients with high clinical suspicion.